Antidiabetic and antihyperlipidaemic effects of Solanum xanthocarpum total extracts in alloxan induced diabetic rats

Pharmacologyonline

Volumn 1, Issue , 2009, Pages 484-497

  Gupta, Amartya K ^a   Ganguly, Partha ^a   Majumder, Upal K ^a   Ghosal, Shibnath ^b  

^a JADAVPUR UNIVERSITY   (India)

^b Indian Herbs Ltd   (India)

Author keywords

Alloxan; Antidiabetic; Antihyperlipidaemic; Glibenclamide; Solanum xanthocarpum

Indexed keywords

ALKALOID DERIVATIVE; AMINO ACID DERIVATIVE; ANTIDIABETIC AGENT; FLAVONOID; GLIBENCLAMIDE; GLUCOSE; GLYCOALKALOID DERIVATIVE; LIPID; PHYTOSTEROL; PLANT EXTRACT; SAPONIN DERIVATIVE; SOLANUM XANTHOCARPUM EXTRACT; SPIROSTA STEROIDAL SAPONIN DERIVATIVE; TANNIN DERIVATIVE; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; NONHUMAN; RAT; SOLANUM; SOLANUM XANTHOCARPUM; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 65549167864     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Li WL, Zheng HC, Bukura J, Dekimbe N. Natural medicines used in the traditional chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 2004; 92: 1-21.
2. Bain SC, Kelly AM, Mijovic CH, Barnett AH. Genetic factors in the pathogenesis of Type-I diabetes. In: Pickup JC, William G, eds. Textbook of diabetes, oxford: Blckwell Scientific Publication 1996; 15.1-16.1.
3. Froguel P, Vaxillaire M. Genetic factors in the pathogenesis of Type 2 diabetes. In: Pickup JC, William G, eds. Textbook of diabetes, oxford: Blckwell Scientific Publication 1996; 20.1-21.1.
4. Olefasky JM. Diabetes mellitus. In: Wyngarden JB, Smith LH, Bennett JC, editors. Text Book of Medicine. Philadalphia: WB Saunders; 1992.
5. Robert WM, Thomas PB. Drug therapy for hypercholesterolemia and dyslipidimia. In: Hardman JG, Limberd LE, Gilman AG, editors. The pharmacological basis of therapeutics. 10th ed. McGraw-hill; 2001.
6. Frode TS, Medeiros YS. Animal models to test drugs with potential antidiabetic activity. J Ethnopharmacol 2008; 115:173-183.
7. Nadkarni AK. Indian Materia Medica. Vol. I. 3rd Edn., Popular Book Depot, Bombay 1954; 1153-1158.
8. Kirtikar KR, Basu BD. Indian Medicinal Plants, Dehradun. Bishen Singh, mahendra Pal singh Publishers 1975; 2: 872.
9. Ghani A. Medicinal plants of Bangladesh-chemical constituents and uses. Dhaka: Asiatic Society of Bangladesh 1998.
10. Kar DM, Maharana L, Pattnaik S, Dash GK. Studies on hypoglycemic activity of Solanum xanthocarpum Schrad. & Wendl. Fruit extracts in rats. J Ethnopharmacol 2006; 108: 251-256.
11. Sridevi M, Senthil S, Pugalendi KV. Antihyperglycemic effect of Solanum surattense leaf-extract in streptozotocin induced diabetic rats. Journal of Pharmacology and Toxicology 2007; 2: 621-629.
12. Gupta S, Mal M, Bhattacharya P. Evaluation of hypoglycemic potential of Solanum xanthocarpum (Solanaceae) fruits in normal and streptozotocin induced diabetic rats. European Bulletin of Drug Research 2005; 13: 51-55.
13. 14C]-streptozotocin with special reference to the pancreatic islets. Acta Endocrinol 1978; 89: 339.
14. Gandy SE, Buse MG, Crouch RK. Protective role of superoxide dismutase against diabetogenic drugs. J Clin Invest 1982; 70: 650.
15. Kwon NS, Lee SH, Choi CS, Kho T, Lee HS. Nitric oxide generation from streptozotocin. FASEB J 1994; 8: 529-534.
16. Wilson GL, Patton nNJ, McCord JM, Mullins DW, Mossman BT. Mechanisms of streptozotocin and alloxan induced damage in rat β cells. Diabetologia 1984; 27: 587.
17. Lenzen S, Panten U. Glucokinase in pancreatic β-cells and its inhibition by alloxan. Acta Endocrinol. 1987; 115: 21-29.
18. Lenzen S, Panten U. signal recognition by pancreatic β-cells and its inhibition by alloxan. Biochem Pharmacol 1988; 37: 371-378.
19. Andrade SA, Monsalve MCR, Pena JE, Polanco AC, Palomino MAP, velasco AF. Streptozotocin and alloxan in experimental diabetes: comparison of the two models in rats. Acta Histochem Cytochem 2000; 33: 201-208.
20. Trease GE, Evans WC. Pharmacognosy. 13th Edn., English Language Book Society, Bailliere Tindall, Britain 1989; 378-480.
21. Trinder P. Determination of blood glucose using an oxidase-perioxidase system with a noncarcinogenic chromogen. J Clinical Pathology 1969; 22: 158-161.
22. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989; 12: 553-564.
23. Klover PJ, Mooney RA. Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol 2004; 36: 753-758.
24. Chattopadhay RF, Bandyopadhyay M. Effects of Azadirachta indica leaf extract on serum lipid profilechanges in normal and streptozotocin induced diabetic rats. Afr J Biomed Res 2005; 8: 101-4.
25. Verma M, Deshiraju S, Jafri M, Mehta BK. Lipid constituents from Centratherum anthelminticum (seeds). Cheminform 2004; 35: 21.
26. Brunton LL, Lazo JS, parker KL, Goodman and Gilman's The Pharmacological basis of therapeutics, McGraw Hill, New York 2006: 1634.
27. Teotia S, Singh M. Hypoglycemic effect of Prunus amygdalusseeds in albino rabbits. Indian Journal of Experimental Biology 1997; 35: 295-296.
28. Coskum O, Kanter M, Oter S. Quercitin, a flavonoid antioxidant, prevents and protects the streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res 2005; 51: 117-123.
29. Cayen MN, Dvornik D. Effect of diosgenin on lipid metabolism in rats. J Lipid Res 1979; 20: 162-174.